Fig. 4From: Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world studyDFS in patients receiving adjuvant chemotherapy at stage I (A) and II (B). DFS in patients receiving adjuvant radiotherapy at stage III (C). PFS (D) and OS (E) in patients receiving pemetrexed-based chemotherapy as first-line regimen at stage IV or after relapsed. OS in patients at stage IV or after relapsed receiving immunotherapy at any time (F)Back to article page